Palisade Bio Inc. Made Headway
Thu, Dec 29, 2022 at 07:12 PM
Palisade Bio Inc. (PALI:NASDAQ) shot up at $3.22, representing a gain of 77.9%. On Thu, Dec 29, 2022, PALI:NASDAQ hit a New 2-Week High of $3.22. The stock got featured on our News Catalysts scanner on Fri, Dec 16, 2022 at 10:19 AM in the 'BIOTECH' category. From Thu, Dec 15, 2022, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Tue, Nov 15, 2022 at $7 with a volume of 1M+.
About Palisade Bio Inc. (PALI:NASDAQ)
Palisade Bio Inc is a late-stage biopharma company.
Top 10 Gainers:
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 143.64%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 99.04%
- Palisade Bio Inc. (PALI:NASDAQ), 77.9%
- SatixFy Communications Ltd. (SATX:NYSEMKT), 67.68%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 61.22%
- Baudax Bio, Inc. (BXRX:NASDAQ), 56.09%
- Quotient Limited (QTNT:NASDAQ), 54.13%
- Starry Group Holdings Inc. Class A (STRY:NYSE), 49.75%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 45.57%
- Sonendo Inc. (SONX:NYSE), 39.11%